various behavioral choices, and increase endurance
while releasing negative emotional effects. Gratitude
has an aspect of taking wisdom / benefit over not
meeting fulfillment of expectations. Through this
mechanism, gratitude has the advantage of leading
to social ties, thus facilitating a unique path to
prosperity (Emmons and Stern, 2013).
According to Hamka, a philosopher, scholar and
poet, Islam teaches humankind four ways to the
happiness of I'tikad (self-motivated motivation),
belief (strong belief in something he is doing), faith
(proven by oral and deeds), and religion/ad-diin. The
last stage is ad-diin, which is total surrender to God,
perfect self-servitude. Those who run ad-diin well
do not feel sad prolonged because they are
absolutely sure of the path God has chosen for them
(Wibowo, 2013). Similarly, respondents with SLE,
they believe that God does not provide trials beyond
the limits of his ability. This is also seen in their
very high acceptance level. Though SLE obstructs
their daily activities, yet in every condition they
always think of God's blessings. They perceive the
condition of SLE suffered is the way God loves
them so that they always remember God and do
good. This makes the subject adapt and reconcile
with SLE.
4 CONCLUSIONS
SLE causes a severe manifestation of the sufferer.
Until now there is no treatment that can cure SLE.
This condition is exacerbated by the side effects of
steroid drugs and immunosuppresses that have been
used to relieve attacks. On the basis of gratitude,
people with SLE who join the SDF organization
choose coping strategies of religion, emotional
control, and environmental support so that people
with SLE can feel the ultimate happiness in the long-
suffering SLE. SLE patients are always grateful in
the heart, spoken, and applied in everyday life in
order to get a good subjective well-being.
REFERENCES
Bosma, G.P.T., Middelkoop, H.A.M., Rood, M.J., Bollen,
E.L.E.M., Huizinga, T.W.J., Van Buchem, M.A.,
2002. Association of global brain damage and clinical
functioning in neuropsychiatric systemic lupus
erythematosus. Arthritis Rheum. 46, 2665–2672.
doi:10.1002/art.10574.
Cervera, R., Khamashta, M.A., Font, J., Sebastiani, G.D.,
Gil, A., Lavilla, P., Mejía, J.C., Aydintug, A.O.,
Chwalinska-Sadowska, H., de Ramón, E., Fernández-
Nebro, A., Galeazzi, M., Valen, M., Mathieu, A.,
Houssiau, F., Caro, N., Alba, P., Ramos-Casals, M.,
Ingelmo, M., Hughes, G.R.V., 2003. Morbidity and
Mortality in Systemic Lupus Erythematosus During a
10-Year Period. Medicine (Baltimore). 82, 299–308.
doi:10.1097/01.md.0000091181.93122.55.
Chiewthanakul, P., Sawanyawisuth, K., Foocharoen, C.,
Tiamkao, S., 2012. Original article Clinical features
and predictive factors in neuro- psychiatric lupus
Table 1. Neuropsychiatric syndromes observed in
systemic lupus erythematosus (NPSLE) a 2012.
DeWall, C., Lambert, N., Jr, R.P., 2012. A grateful heart
is a nonviolent heart: Cross-sectional, experience
sampling, longitudinal, and experimental evidence.
Social.
Diener, E., Pressman, S.D., Hunter, J., Delgadillo-Chase,
D., 2017. If, Why, and When Subjective Well-Being
Influences Health, and Future Needed Research. Appl.
Psychol. Heal. Well-Being 9, 133–167.
doi:10.1111/aphw.12090.
Emmons, R., Stern, R., 2013. Gratitude as a
psychotherapeutic intervention. J. Clin. Psychol.
Ginzler, E.M., Wallace, D.J., Merrill, J.T., Furie, R.A.,
Stohl, W., Chatham, W.W., Weinstein, A., McKay,
J.D., McCune, W.J., Zhong, Z.J., Freimuth, W.W.,
Petri, M.A., 2014. Disease control and safety of
belimumab plus standard therapy over 7 years in
patients with systemic lupus erythematosus. J.
Rheumatol. 41, 300–309. doi:10.3899/jrheum.121368
Greenberg, B., Michalska, M., 1999. Systemic lupus
erythematosus. Postgrad. Med. 106, 213–223.
doi:10.3810/pgm.1999.11.779.
Huppert, F.A., So, T.T.C., 2013. Flourishing Across
Europe: Application of a New Conceptual Framework
for Defining Well-Being. Soc. Indic. Res. 110, 837–
861. doi:10.1007/s11205-011-9966-7.
Lin, C., 2015. Self-esteem mediates the relationship
between dispositional gratitude and well-being. Pers.
Individ. Dif.
Manger, K., Manger, B., Repp, R., Geisselbrecht, M.,
Geiger, A., Pfahlberg, A., Harrer, T., Kalden, J., 2002.
Definition of risk factors for death, end stage renal
disease, and thromboembolic events in a monocentric
cohort of 338 patients with systemic lupus
erythematosus 1065–1070.
Pego-Reigosa, J.M., Cobo-Ibáñez, T., Calvo-Alén, J.,
Loza-Santamaría, E., Rahman, A., Muñoz-Fernández,
S., Rúa-Figueroa, Í., 2013. Efficacy and safety of
nonbiologic immunosuppressants in the treatment of
nonrenal systemic lupus erythematosus: A systematic
review. Arthritis Care Res. 65, 1775–1785.
doi:10.1002/acr.22035.
Petri, M., Orbai, A.M., Alarc??n, G.S., Gordon, C.,
Merrill, J.T., Fortin, P.R., Bruce, I.N., Isenberg, D.,
Wallace, D.J., Nived, O., Sturfelt, G., Ramsey-
Goldman, R., Bae, S.C., Hanly, J.G., S??nchez-
Guerrero, J., Clarke, A., Aranow, C., Manzi, S.,
Urowitz, M., Gladman, D., Kalunian, K., Costner, M.,
Werth, V.P., Zoma, A., Bernatsky, S., Ruiz-Irastorza,
Happiness in Suffering of Systemic Lupus Erythematosus: Does It Make Sense?
67